RBC Capital Lowers athenahealth Price Target to $140.00 (ATHN)
Research analysts at RBC Capital reduced their price target on shares of athenahealth (NASDAQ:ATHN) from $180.00 to $140.00 in a report released on Monday, Analyst Ratings Network.com reports. The firm currently has a “sector perform” rating on the stock. RBC Capital’s price target points to a potential upside of 3.25% from the stock’s previous close.
A number of other analysts have also recently weighed in on ATHN. Analysts at FBR Capital Markets raised their price target on shares of athenahealth from $115.00 to $125.00 in a research note on Monday. They now have a “market perform” rating on the stock. Separately, analysts at ISI Group cut their price target on shares of athenahealth from $163.00 to $159.00 in a research note on Monday. They now have a “neutral” rating on the stock. Finally, analysts at Jefferies Group upgraded shares of athenahealth from an “underperform” rating to a “hold” rating in a research note on Monday. They now have a $145.00 price target on the stock, up previously from $135.00. One analyst has rated the stock with a sell rating, fifteen have assigned a hold rating and nine have issued a buy rating to the stock. The stock currently has a consensus rating of “Hold” and an average target price of $165.61.
Shares of athenahealth (NASDAQ:ATHN) traded down 6.86% on Monday, hitting $135.59. The stock had a trading volume of 2,115,590 shares. athenahealth has a one year low of $82.01 and a one year high of $206.70. The stock’s 50-day moving average is $169.2 and its 200-day moving average is $146.1. The company’s market cap is $5.082 billion.
athenahealth (NASDAQ:ATHN) last announced its earnings results on Thursday, April 17th. The company reported $0.12 EPS for the quarter, missing the Thomson Reuters consensus estimate of $0.17 by $0.05. The company had revenue of $163.00 million for the quarter, compared to the consensus estimate of $170.03 million. During the same quarter in the prior year, the company posted $0.38 earnings per share. The company’s quarterly revenue was up 29.8% on a year-over-year basis. On average, analysts predict that athenahealth will post $1.08 earnings per share for the current fiscal year.
In other athenahealth news, Insider Stephen Kahane sold 10,000 shares of the stock in a transaction dated Wednesday, April 16th. The shares were sold at an average price of $143.96, for a total value of $1,439,600.00. Following the completion of the transaction, the insider now directly owns 69,285 shares in the company, valued at approximately $9,974,269. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this link.
athenahealth, Inc (NASDAQ:ATHN), is a business services company, which provides ongoing billing, clinical-related, and other related services to its customers.
Get Analysts' Upgrades and Downgrades via Email - Stay on top of analysts' coverage with Analyst Ratings Network's FREE daily email newsletter that provides a concise list of analysts' upgrades and downgrades. Click here to register now.